The regulatory landscape for actively personalized cancer immunotherapies

Cedrik M. Britten; Harpreet Singh-Jasuja; Bruno Flamion; Axel Hoos; Christoph Huber; Karl Josef Kallen; Samir N. Khleif; Sebastian Kreiter; Michaela Nielsen; Hans Georg Rammensee; Ugur Sahin; Thomas Hinz; Ulrich Kalinke

doi:10.1038/nbt.2708

The regulatory landscape for actively personalized cancer immunotherapies

Cedrik M. Britten, Harpreet Singh-Jasuja, Bruno Flamion, Axel Hoos, Christoph Huber, Karl Josef Kallen, Samir N. Khleif, Sebastian Kreiter, Michaela Nielsen, Hans Georg Rammensee, Ugur Sahin, Thomas Hinz, Ulrich Kalinke

Research output: Contribution to journal › Letter › peer-review

50 Scopus citations

Original language	English (US)
Pages (from-to)	880-882
Number of pages	3
Journal	Nature Biotechnology
Volume	31
Issue number	10
DOIs	https://doi.org/10.1038/nbt.2708
State	Published - Oct 2013
Externally published	Yes

ASJC Scopus subject areas

Biotechnology
Bioengineering
Biomedical Engineering
Applied Microbiology and Biotechnology
Molecular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/nbt.2708

Cite this

@article{ac813b26b4a945a6808c082f0b601fc9,

title = "The regulatory landscape for actively personalized cancer immunotherapies",

author = "Britten, {Cedrik M.} and Harpreet Singh-Jasuja and Bruno Flamion and Axel Hoos and Christoph Huber and Kallen, {Karl Josef} and Khleif, {Samir N.} and Sebastian Kreiter and Michaela Nielsen and Rammensee, {Hans Georg} and Ugur Sahin and Thomas Hinz and Ulrich Kalinke",

year = "2013",

month = oct,

doi = "10.1038/nbt.2708",

language = "English (US)",

volume = "31",

pages = "880--882",

journal = "Nature Biotechnology",

issn = "1087-0156",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - The regulatory landscape for actively personalized cancer immunotherapies

AU - Britten, Cedrik M.

AU - Singh-Jasuja, Harpreet

AU - Flamion, Bruno

AU - Hoos, Axel

AU - Huber, Christoph

AU - Kallen, Karl Josef

AU - Khleif, Samir N.

AU - Kreiter, Sebastian

AU - Nielsen, Michaela

AU - Rammensee, Hans Georg

AU - Sahin, Ugur

AU - Hinz, Thomas

AU - Kalinke, Ulrich

PY - 2013/10

Y1 - 2013/10

UR - http://www.scopus.com/inward/record.url?scp=84885659334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885659334&partnerID=8YFLogxK

U2 - 10.1038/nbt.2708

DO - 10.1038/nbt.2708

M3 - Letter

C2 - 24104749

AN - SCOPUS:84885659334

SN - 1087-0156

VL - 31

SP - 880

EP - 882

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 10

ER -

The regulatory landscape for actively personalized cancer immunotherapies

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this